Clinical Trial Update: Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of eslicarbazepine monotherapy in patients with partial epilepsy not well controlled by current antiepileptic drugs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2015-12-21